Randomised controlled trial protocol to evaluate a fixed dose prothrombin complex concentrate against the variable dose in vitamin K antagonist related bleeding (PROPER3)

por Abdoellakhan, Rahat A, Khorsand, Nakisa, Van Hest, Reinier M, Veeger, Nic, Ter Avest, Ewoud, Ypma, Paula F, Faber, Laura M, Meijer, Karina
Publicado en BMJ Open (2018)

Chest X-Ray Not Routinely Indicated Prior to the YEARS Algorithm in the Diagnostic Management of Suspected Pulmonary Embolism

por van der Pol, Liselotte M., Tromeur, Cecile, Faber, Laura M., van der Hulle, Tom, Kroft, Lucia J. M., Mairuhu, Albert T. A., de Roos, Albert, Huisman, Menno V., Klok, Frederikus A.
Publicado en TH Open (2019)

The Effect of SF3B1 Mutation on the DNA Damage Response and Nonsense-Mediated mRNA Decay in Cancer

por Leeksma, Alexander C., Derks, Ingrid A. M., Kasem, M. Haidar, Kilic, Emine, de Klein, Annelies, Jager, Martine J., van de Loosdrecht, Arjan A., Jansen, Joop H., Navrkalova, Veronika, Faber, Laura M., Zaborsky, Nadja, Egle, Alexander, Zenz, Thorsten, Pospisilova, Sarka, Abdel-Wahab, Omar, Kater, Arnon P., Eldering, Eric
Publicado en Front Oncol (2021)

Uncertain Value of High‐sensitive Troponin T for Selecting Patients With Acute Pulmonary Embolism for Outpatient Treatment by Hestia Criteria

por Hendriks, Stephan V., Lankeit, Mareike, den Exter, Paul L., Zondag, Wendy, Brouwer, Rolf, Eijsvogel, Michiel, Grootenboers, Marco J., Faber, Laura M., Heller‐Baan, Roxanne, Hofstee, Herman M. A., Iglesias del Sol, Antonio, Mairuhu, Albert T. A., Melissant, Christian F., Peltenburg, Henny G., van de Ree, Marcel A., Serné, Erik H., Konstantinides, Stavros, Klok, Frederikus A., Huisman, Menno V.
Publicado en Acad Emerg Med (2020)

Cereblon loss and up-regulation of c-Myc are associated with lenalidomide resistance in multiple myeloma patients

por Franssen, Laurens E., Nijhof, Inger S., Couto, Suzana, Levin, Mark-David, Bos, Gerard M.J., Broijl, Annemiek, Klein, Saskia K., Ren, Yan, Wang, Maria, Koene, Harry R., Bloem, Andries C., Beeker, Aart, Faber, Laura M., van der Spek, Ellen, Raymakers, Reinier, Leguit, Roos J., Sonneveld, Pieter, Zweegman, Sonja, Lokhorst, Henk, Mutis, Tuna, Thakurta, Anjan, Qian, Xiaozhong, van de Donk, Niels W.C.J.
Publicado en Haematologica (2018)

Heavy menstrual bleeding on direct factor Xa inhibitors: Rationale and design of the MEDEA study

por Hamulyák, Eva N., Wiegers, Hanke M. G., Scheres, Luuk J. J., Hutten, Barbara A., de Lange, Maria E., Timmermans, Anne, Westerweel, Peter E., Nijziel, Marten R., Kruip, Marieke J. H. A., ten Wolde, Marije, Ypma, Paula F., Klok, Frederikus A., Nieuwenhuizen, Laurens, van Wissen, Sanne, Hovens, Marcel M. C., Faber, Laura M., Kamphuisen, Pieter W., Büller, Harry R., Middeldorp, Saskia
Publicado en Res Pract Thromb Haemost (2020)

Lenalidomide combined with low-dose cyclophosphamide and prednisone modulates Ikaros and Aiolos in lymphocytes, resulting in immunostimulatory effects in lenalidomide-refractory mu...

por Franssen, Laurens E., Nijhof, Inger S., Bjorklund, Chad C., Chiu, Hsiling, Doorn, Ruud, van Velzen, Jeroen, Emmelot, Maarten, van Kessel, Berris, Levin, Mark-David, Bos, Gerard M.J., Broijl, Annemiek, Klein, Saskia K., Koene, Harry R., Bloem, Andries C., Beeker, Aart, Faber, Laura M., van der Spek, Ellen, Raymakers, Reinier, Sonneveld, Pieter, Zweegman, Sonja, Lokhorst, Henk M., Thakurta, Anjan, Qian, Xiaozhong, Mutis, Tuna, van de Donk, Niels W.C.J.
Publicado en Oncotarget (2018)